References
- Muratov EN, Bajorath J, Sheridan RP, et al. QSAR without borders. Chem Soc Rev. 2020;49(11):3525–3564.
- Brown N, Ertl P, Lewis R, et al. Artificial intelligence in chemistry and drug design. J Comput-Aided Mol Des. 2020;34(7):709–715.
- Sellwood MA, Ahmed M, Segler MH, et al. Artificial intelligence in drug discovery. Future Med Chem. 2018;10(17):2025–2028.
- Baskin II. The power of deep learning to ligand-based novel drug discovery. Expert Opin Drug Discov. 2020;15(7):756–764.
- Varnek A, Baskin I. Machine learning methods for property prediction in chemoinformatics: quo vadis? J Chem Inf Model. 2012;52(6):1413–1437.
- Simón-Vidal L, García-Calvo O, Oteo U, et al. Perturbation-theory and machine learning (PTML) model for high-throughput screening of Parham reactions: experimental and theoretical studies. J Chem Inf Model. 2018;58(7):1384–1396.
- Livingstone DJ, Salt DW. Variable selection - spoilt for choice? Rev Comp Chem. 2005;21:287–348.
- Tetko IV, Solov’ev VP, Antonov AV, et al. Benchmarking of linear and nonlinear approaches for quantitative structure-property relationship studies of metal complexation with ionophores. J Chem Inf Model. 2006;46(2):808–819.
- Baskin II, Winkler D, Tetko IV. A renaissance of neural networks in drug discovery. Expert Opin Drug Discov. 2016;11(8):785–795.
- Simões RS, Maltarollo VG, Oliveira PR, et al. Transfer and multi-task learning in QSAR modeling: advances and challenges. Front Pharmacol. 2018;9:74.
- Varnek A, Gaudin C, Marcou G, et al. Inductive transfer of knowledge: application of multi-task learning and feature net approaches to model tissue-air partition coefficients. J Chem Inf Model. 2009;49(1):133–144.
- Kondratovich E, Baskin II, Varnek A. Transductive support vector machines: promising approach to model small and unbalanced datasets. Mol Inf. 2013;32(3):261–266.
- Fujiwara Y, Yamashita Y, Osoda T, et al. Virtual screening system for finding structurally diverse hits by active learning. J Chem Inf Model. 2008;48(4):930–940.
- Baskin II. Is one-shot learning a viable option in drug discovery? Expert Opin Drug Discov. 2019;14(7):601–603.
- Kireeva N, Baskin II, Gaspar HA, et al. Generative Topographic Mapping (GTM): universal Tool for Data Visualization, Structure-Activity Modeling and Dataset Comparison. Mol Inf. 2012;31(3–4):301–312.
- Polishchuk P. Interpretation of quantitative structure–activity relationship models: past, present, and future. J Chem Inf Model. 2017;57(11):2618–2639.